R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

On a journey to diverse, inclusive, and more efficient rare ...

Although orphan drugs represent a sizeable portion of new drug approvals,1most rare diseases still lack effective treatment.

R&D

Evolving with the patient: Optimising CAGT post-trial long-t...

The tremendous growth in cell and gene therapy is no surprise to the pharma industry.

R&D

The longitudinal history of medicines innovation: Part One

As we move forwards in public discussions on pharmaceutical innovation and its value to patients and society, it is helpful to ground conversations in a solid understanding of how medicines

R&D

One Health: The interconnection of animal and human health

There’s a tendency to overlook the fact that human health and animal health are closely intertwined.

R&D

Navigating EAPs: Clinical trials and the path to investigati...

Medical breakthroughs have always been milestones lighting our path to better health.

Patients

How the rise of medical device use in pharma R&D is driving ...

As wearable technologies continue to rapidly develop, the use cases for wearable devices evolve and expand.